Identification
The chromatogram of the
Assay preparation obtained as directed in the
Assay exhibits a major peak for tetracycline, the retention time of which corresponds to that exhibited in the chromatogram of the
Standard preparation obtained as directed in the
Assay.
Limit of 4-epianhydrotetracycline
Using the
Diluting solvent,
Chromatographic system, and
Procedure set forth in the
Assay, chromatograph a Standard solution prepared by dissolving an accurately weighed quantity of
USP 4-Epianhydrotetracycline Hydrochloride RS in
Diluting solvent to obtain a solution having a known concentration of about 10 µg per mL. Using the chromatogram so obtained and the chromatogram of the
Assay preparation obtained as directed in the
Assay, calculate the percentage of 4-epianhydrotetracycline in the Oral Suspension taken by the formula:
(25CE / T)(rU / rS),
in which
CE is the concentration, in µg per mL, of
USP 4-Epianhydrotetracycline Hydrochloride RS in the Standard solution,
T is the quantity, in mg, of tetracycline hydrochloride equivalent in the portion of Oral Suspension taken, based on the labeled quantity, and
rU and
rS are the 4-epianhydrotetracycline peak responses obtained from the
Assay preparation and the Standard solution, respectively: not more than 5.0% is found.
Assay
Diluting solvent, Mobile phase, Standard preparation, Resolution solution, and Chromatographic system
Prepare as directed in the
Assay under
Tetracycline Hydrochloride.
Assay preparation
Transfer an accurately measured volume of Oral Suspension, equivalent to about 125 mg of tetracycline hydrochloride, to a 250-mL volumetric flask, add 200 mL of Diluting solvent, and shake. Add Diluting solvent to volume, mix, and filter.
Procedure
Proceed as directed in the
Assay under
Tetracycline Hydrochloride. Calculate the quantity, in mg per mL, of C
22H
24N
2O
8·HCl equivalent in the Oral Suspension taken by the formula:
(CP / 4V)(rU / rS),
in which
V is the volume, in mL, of Oral Suspension taken, and the other terms are as defined therein.